CCCC Short Term Debt from 2010 to 2024
| CCCC Stock | USD 5.00 0.02 0.40% |
Short Term Debt | First Reported 2010-12-31 | Previous Quarter 5.2 M | Current Value 3 M | Quarterly Volatility 1.9 M |
Check C4 TherapeuticsInc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CCCC main balance sheet or income statement drivers, such as Tax Provision of 1.3 M, Net Interest Income of 6.9 M or Interest Income of 9 M, as well as many exotic indicators such as Price To Sales Ratio of 12.84, Dividend Yield of 0.0 or PTB Ratio of 1.2. CCCC financial statements analysis is a perfect complement when working with C4 TherapeuticsInc Valuation or Volatility modules.
CCCC | Short Term Debt |
Latest C4 TherapeuticsInc's Short Term Debt Growth Pattern
Below is the plot of the Short Term Debt of C4 TherapeuticsInc over the last few years. It is C4 TherapeuticsInc's Short Term Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in C4 TherapeuticsInc's overall financial position and show how it may be relating to other accounts over time.
| Short Term Debt | 10 Years Trend |
|
Short Term Debt |
| Timeline |
CCCC Short Term Debt Regression Statistics
| Arithmetic Mean | 1,669,151 | |
| Geometric Mean | 1,150,500 | |
| Coefficient Of Variation | 114.98 | |
| Mean Deviation | 1,355,708 | |
| Median | 734,000 | |
| Standard Deviation | 1,919,267 | |
| Sample Variance | 3.7T | |
| Range | 6.3M | |
| R-Value | 0.64 | |
| Mean Square Error | 2.3T | |
| R-Squared | 0.42 | |
| Significance | 0.01 | |
| Slope | 276,564 | |
| Total Sum of Squares | 51.6T |
CCCC Short Term Debt History
About C4 TherapeuticsInc Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include C4 TherapeuticsInc income statement, its balance sheet, and the statement of cash flows. C4 TherapeuticsInc investors use historical funamental indicators, such as C4 TherapeuticsInc's Short Term Debt, to determine how well the company is positioned to perform in the future. Although C4 TherapeuticsInc investors may use each financial statement separately, they are all related. The changes in C4 TherapeuticsInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on C4 TherapeuticsInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on C4 TherapeuticsInc Financial Statements. Understanding these patterns can help to make the right decision on long term investment in C4 TherapeuticsInc. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Short Term Debt | 5.2 M | 3 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether C4 TherapeuticsInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of C4 TherapeuticsInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of C4 Therapeuticsinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on C4 Therapeuticsinc Stock:Check out the analysis of C4 TherapeuticsInc Correlation against competitors. For information on how to trade CCCC Stock refer to our How to Trade CCCC Stock guide.Note that the C4 TherapeuticsInc information on this page should be used as a complementary analysis to other C4 TherapeuticsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for CCCC Stock analysis
When running C4 TherapeuticsInc's price analysis, check to measure C4 TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy C4 TherapeuticsInc is operating at the current time. Most of C4 TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of C4 TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move C4 TherapeuticsInc's price. Additionally, you may evaluate how the addition of C4 TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is C4 TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of C4 TherapeuticsInc. If investors know CCCC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about C4 TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.37) | Revenue Per Share 0.368 | Quarterly Revenue Growth (0.19) | Return On Assets (0.21) | Return On Equity (0.48) |
The market value of C4 TherapeuticsInc is measured differently than its book value, which is the value of CCCC that is recorded on the company's balance sheet. Investors also form their own opinion of C4 TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is C4 TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because C4 TherapeuticsInc's market value can be influenced by many factors that don't directly affect C4 TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between C4 TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if C4 TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, C4 TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.